Chikungunya virus burden and implications for vaccination programs

IF 58.7 1区医学 Q1 BIOCHEMISTRY & MOLECULAR BIOLOGY

Nature Medicine Pub Date : 2025-06-27 DOI:10.1038/s41591-025-03812-6

引用次数: 0

Abstract

Widely spread around the globe, chikungunya virus (CHIKV) is a mosquito-borne virus that can cause severe acute disease, sometimes followed by debilitating chronic joint pain. This study provides estimates of the burden of CHIKV infection on public health for 180 countries and evaluates the potential benefits of vaccination campaigns.

查看原文本刊更多论文

基孔肯雅病毒负担及其对疫苗接种规划的影响

基孔肯雅病毒（CHIKV）是一种蚊子传播的病毒，在全球广泛传播，可引起严重的急性疾病，有时随后会出现使人衰弱的慢性关节疼痛。本研究估计了180个国家的CHIKV感染对公共卫生造成的负担，并评估了疫苗接种运动的潜在益处。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文求助全文

来源期刊

Nature Medicine 医学-生化与分子生物学

CiteScore

100.90

自引率

0.70%

发文量

525

审稿时长

1 months

期刊介绍： Nature Medicine is a monthly journal publishing original peer-reviewed research in all areas of medicine. The publication focuses on originality, timeliness, interdisciplinary interest, and the impact on improving human health. In addition to research articles, Nature Medicine also publishes commissioned content such as News, Reviews, and Perspectives. This content aims to provide context for the latest advances in translational and clinical research, reaching a wide audience of M.D. and Ph.D. readers. All editorial decisions for the journal are made by a team of full-time professional editors. Nature Medicine consider all types of clinical research, including: -Case-reports and small case series -Clinical trials, whether phase 1, 2, 3 or 4 -Observational studies -Meta-analyses -Biomarker studies -Public and global health studies Nature Medicine is also committed to facilitating communication between translational and clinical researchers. As such, we consider “hybrid” studies with preclinical and translational findings reported alongside data from clinical studies.